We are live on
!
Find out more
PMV Pharmaceuticals
PMVP
PMVP
69 hedge funds and large institutions have $45.8M invested in PMV Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
10% more funds holding
Funds holding: 63 → 69 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $46.8M → $45.8M (-$941K)
1.02% less ownership
Funds ownership: 70.33% → 69.31% (-1%)
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
Holders
69
Holders Change
+6
Holders Change %
+9.52%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
16
Reduced
20
Closed
8
Calls
$108K
Puts
–
Net Calls
+$108K
Net Calls Change
+$41K
Top Buyers
| 1 |
EP
Eversept Partners
New York
|
+$2.99M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.37M |
| 3 |
Two Sigma Investments
New York
|
+$1.5M |
| 4 |
Morgan Stanley
New York
|
+$973K |
| 5 |
LP
Longaeva Partners
Chicago,
Illinois
|
+$702K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$6.22M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$884K |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$563K |
| 4 |
Jane Street
New York
|
-$476K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$438K |